SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations

by Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, Tomasz Lipniacki
Published 2021-03-01